A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Brexpiprazole for Extended-Release Injection in Subjects With Schizophrenia

NCT07742280 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Brexpiprazole for ER injection, 45 mg
DRUG: Brexpiprazole for ER injection, 100 mg

Sponsor

Bostal Drug Delivery Co., Ltd